alendronate has been researched along with iloprost in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckmann, J; Fischer, A; Heiss, C; Jäger, M; Maus, U; Nöth, U; Peters, KM; Rader, C; Reppenhagen, S; Roth, A; Smolenski, U; Tingart, M | 1 |
Beckmann, J; Bohndorf, K; Breusch, SJ; Fischer, A; Heiß, C; Jäger, M; Kenn, W; Kopp, I; Maus, U; Nöth, U; Peters, KM; Rader, C; Reppenhagen, S; Roth, A; Sirotin, I; Smolenski, U; Tingart, M | 1 |
1 review(s) available for alendronate and iloprost
Article | Year |
---|---|
S3-Guideline non-traumatic adult femoral head necrosis.
Topics: Adult; Alendronate; Arthroplasty, Replacement, Hip; Bone Density Conservation Agents; Decompression, Surgical; Diagnosis, Differential; Femur Head Necrosis; Hip Prosthesis; Humans; Iloprost; Practice Guidelines as Topic; Vasodilator Agents | 2016 |
1 other study(ies) available for alendronate and iloprost
Article | Year |
---|---|
[S3 guideline. Part 2: Non-Traumatic Avascular Femoral Head Necrosis in Adults - Untreated Course and Conservative Treatment].
Topics: Alendronate; Bone Density Conservation Agents; Evidence-Based Medicine; Female; Femoral Fractures; Femur Head Necrosis; Germany; Humans; Iloprost; Male; Orthopedics; Practice Guidelines as Topic; Treatment Outcome | 2015 |